News
Initially identified as a proto-oncogene, c-Fos is essential for neural activity, synaptic plasticity, and stress responses. While its transient expression supports memory formation in healthy brains, ...
Neuroinflammation is one of the key factors in the progression of Alzheimer's disease (AD). Sustained overactivation of inflammation exacerbates neuronal damage, underscoring the need for targeted ...
Discover how Parkinson's disease begins in the gut, not the brain. Learn the early digestive warning signs that appear years ...
At a presentation given last week at Auburn University, researchers discussed recent advancements in the understanding and ...
DelveInsight's Alzheimer's Disease Pipeline report depicts a robust space with 200+ active players working to develop 220+ ...
Sleep disorders may lead to structural brain changes, cognitive decline, and neurological disease. Here’s what science says about the risk.
CD2AP and Alzheimer’s disease: A key regulator of neurodegeneration and potential therapeutic target
and neuroinflammation . “CD2AP is a fascinating molecule because it functions at the intersection of multiple pathways implicated in Alzheimer’s disease,” said Professor Yun-wu Zhang ...
It would help the trials—and patients—if more people were tested for Alzheimer’s earlier on, so that they could be enrolled ...
(TNND) — A study at the University of Virginia might offer hope to Alzheimer's patients in the future. Researchers found that ...
Brain tissue analysis of an animal model has revealed the potential role of immune system dysfunction in the onset and progression of Alzheimer's disease (AD). Published April 15, 2025 in the ...
16d
News Medical on MSNKey Protein in Astrocytes Drives Alzheimer’s Disease NeurodegenerationResearchers at the University of Barcelona discovered the RTP801 protein's key involvement in Alzheimer’s cognitive decline, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results